Rubait Hasan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Rubait Hasan has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Mohammad Shahangir Biswas
Department of Biochemistry and Biotechnology University of Science & Technology Chittagong (USTC) Chittagong Bangladesh
3 shared publications - Aoulia Yeasmin
Department of Botany, Sirajganj Govt. College, Sirajganj 6700, Bangladesh
1 shared publication - Ataur Rahman
Department of Genetic Engineering and Biotechnology, University of Rajshahi, Motihar, Rajshahi 6205, Bangladesh
1 shared publication - Faruk Hossain
Department of Biochemistry and Biotechnology, School of Biomedical Science, Khwaja Yunus Ali University, Sirajganj 6751, Bangladesh
1 shared publication - Foyzur Rahman
Department of Biochemistry and Biotechnology, Khwaja Yunus Ali University , Sirajganj 6751, Bangladesh
1 shared publication - Hasanuzzaman Manik
Department of Genetic Engineering and Biotechnology, University of Rajshahi, Motihar, Rajshahi 6205, Bangladesh
1 shared publication
Latest Publications
- Open Access
- 1 January 2025
- Published by Wiley in Journal of Food Biochemistry
- Vol. 2025 (1)
Toxic Effects of Green Leaf Color (GLC) in Swiss Albino Mice: A Molecular and Histopathological Approach
Synthetic food dyes are commonly used to enhance food appearance, yet their potential health risks remain a concern. Green leaf color (GLC), a synthetic dye widely employed in diverse applications such as fashion, product design, and branding, is predominantly used in foods in Bangladesh, where its toxicity has not been comprehensively assessed. This study aimed to investigate the toxicological effects of GLC on growth performance, hematological and biochemical parameters, tissue architecture, and molecular markers in Swiss albino mice. Forty mice were divided into four groups: one control and three treatment groups, receiving oral doses of GLC at 125 (low), 250 (medium), and 500 (high) mg/kg body weight daily for 13 weeks. GLC exposure significantly impaired growth in treated mice and reduced feed efficiency in a dose‐dependent manner compared to the controls. Hematological analysis revealed marked reductions in hemoglobin, hematocrit, and MCH, with significant increases in WBC, platelets, and monocyte counts. Biochemical examination showed elevated levels of ALP, ALT, AST, bilirubin, urea, and creatinine. Histological evaluation demonstrated multiorgan damage, including central vein congestion, hepatocellular vacuolization, and inflammatory cell infiltration in the liver; glomerular atrophy, tubular injury, and interstitial edema in the kidney; and villi destruction, epithelial shedding, and mucosal damage in the intestine. At the molecular level, mRNA expression analysis revealed significant upregulation of BCL-2 and Beclin-1 genes in the liver, kidney, and intestine, whereas BAX was markedly downregulated in the liver and kidney, and NF-κB expression was suppressed in the intestine, indicating GLC‐induced dysregulation of apoptosis and autophagy pathways. This study provides the first comprehensive evaluation of GLC toxicity in mice, integrating biochemical, histological, and molecular evidence. The overall findings demonstrate that GLC induces multilevel toxic effects with potential genotoxic properties. Therefore, strict regulation and preventive measures should be taken to minimize the use of GLC in food products.
- 1 January 2025
- Published by Wiley in Journal of Food Biochemistry
- Vol. 2025 (1)
Open AccessToxic Effects of Green Leaf Color (GLC) in Swiss Albino Mice: A Molecular and Histopathological Approach
Synthetic food dyes are commonly used to enhance food appearance, yet their potential health risks remain a concern. Green leaf color (GLC), a synthetic dye widely employed in diverse applications such as fashion, product design, and branding, is predominantly used in foods in Bangladesh, where its toxicity has not been comprehensively assessed. This study aimed to investigate the toxicological effects of GLC on growth performance, hematological and biochemical parameters, tissue architecture, and molecular markers in Swiss albino mice. Forty mice were divided into four groups: one control and three treatment groups, receiving oral doses of GLC at 125 (low), 250 (medium), and 500 (high) mg/kg body weight daily for 13 weeks. GLC exposure significantly impaired growth in treated mice and reduced feed efficiency in a dose‐dependent manner compared to the controls. Hematological analysis revealed marked reductions in hemoglobin, hematocrit, and MCH, with significant increases in WBC, platelets, and monocyte counts. Biochemical examination showed elevated levels of ALP, ALT, AST, bilirubin, urea, and creatinine. Histological evaluation demonstrated multiorgan damage, including central vein congestion, hepatocellular vacuolization, and inflammatory cell infiltration in the liver; glomerular atrophy, tubular injury, and interstitial edema in the kidney; and villi destruction, epithelial shedding, and mucosal damage in the intestine. At the molecular level, mRNA expression analysis revealed significant upregulation of BCL-2 and Beclin-1 genes in the liver, kidney, and intestine, whereas BAX was markedly downregulated in the liver and kidney, and NF-κB expression was suppressed in the intestine, indicating GLC‐induced dysregulation of apoptosis and autophagy pathways. This study provides the first comprehensive evaluation of GLC toxicity in mice, integrating biochemical, histological, and molecular evidence. The overall findings demonstrate that GLC induces multilevel toxic effects with potential genotoxic properties. Therefore, strict regulation and preventive measures should be taken to minimize the use of GLC in food products.
- Open Access
- 1 January 2025
- Published by Wiley in Journal of Toxicology
- Vol. 2025 (1) , 5464388
Biochemical and Biological Profiles of Bangladeshi Russell’s Viper Snake Venom and Neutralizing Efficacy by Indian VINS Polyvalent Antivenom
The Russell’s viper ( Daboia russelii ) has recently become a significant threat to human life in Bangladesh. Given its wide distribution across South Asia, the venom characteristics and lethality can vary by region with different toxicological properties. Hence, we investigated the characteristics of Bangladeshi Russell’s viper venom (BRVV) through SDS–PAGE profiling, reverse‐phase HPLC analysis, along with assessments of phospholipase A 2 (PLA 2 ), edema‐inducing, hemolytic, hemorrhagic, and coagulant activities, histopathology, and blood biochemistry, following established protocols. We also studied the neutralization efficacy of polyvalent antivenom from VINS Bio Products Ltd., India (VPAV) against BRVV. RP‐HPLC analysis of BRVV displayed 15 peaks, and SDS–PAGE showed high‐intensity protein bands within the 15–70 kDa range. The median lethal dose (LD 50 ) for mice was found to be 0.33 mg/kg intraperitoneally (i.p.), and venom exposure resulted in neurotoxic symptoms such as limb paralysis, respiratory difficulties, and sluggishness. BRVV exhibited strong PLA 2 , procoagulant, hemorrhagic, indirect hemolytic, and edema‐inducing activities but poor direct hemolytic activity. Venom administration also significantly increased levels of alanine aminotransferase (ALT), alkaline phosphatase (ALP), aspartate aminotransferase (AST), cholesterol, total protein, uric acid, blood urea nitrogen (BUN), and creatinine in mouse serum, indicating organ damage. Histopathological examination revealed cell vacuolization, congestion, hemorrhage, inflammatory infiltrations, and necrosis in venom‐exposed tissues, validating the abnormal serum biochemistry. The neutralization study revealed that VPAV had limited efficacy against BRVV, suggesting the presence of venom proteins not fully neutralized by the antivenom. Altogether, these findings suggest that the Russell’s viper is a medically significant venomous snake in Bangladesh, and VPAV is only partially effective in reducing the venom’s toxic effects. Therefore, region‐specific venoms must be considered in antivenom development for more effective treatment in envenomation cases.
- 1 January 2025
- Published by Wiley in Journal of Toxicology
- Vol. 2025 (1) , 5464388
Open AccessBiochemical and Biological Profiles of Bangladeshi Russell’s Viper Snake Venom and Neutralizing Efficacy by Indian VINS Polyvalent Antivenom
The Russell’s viper ( Daboia russelii ) has recently become a significant threat to human life in Bangladesh. Given its wide distribution across South Asia, the venom characteristics and lethality can vary by region with different toxicological properties. Hence, we investigated the characteristics of Bangladeshi Russell’s viper venom (BRVV) through SDS–PAGE profiling, reverse‐phase HPLC analysis, along with assessments of phospholipase A 2 (PLA 2 ), edema‐inducing, hemolytic, hemorrhagic, and coagulant activities, histopathology, and blood biochemistry, following established protocols. We also studied the neutralization efficacy of polyvalent antivenom from VINS Bio Products Ltd., India (VPAV) against BRVV. RP‐HPLC analysis of BRVV displayed 15 peaks, and SDS–PAGE showed high‐intensity protein bands within the 15–70 kDa range. The median lethal dose (LD 50 ) for mice was found to be 0.33 mg/kg intraperitoneally (i.p.), and venom exposure resulted in neurotoxic symptoms such as limb paralysis, respiratory difficulties, and sluggishness. BRVV exhibited strong PLA 2 , procoagulant, hemorrhagic, indirect hemolytic, and edema‐inducing activities but poor direct hemolytic activity. Venom administration also significantly increased levels of alanine aminotransferase (ALT), alkaline phosphatase (ALP), aspartate aminotransferase (AST), cholesterol, total protein, uric acid, blood urea nitrogen (BUN), and creatinine in mouse serum, indicating organ damage. Histopathological examination revealed cell vacuolization, congestion, hemorrhage, inflammatory infiltrations, and necrosis in venom‐exposed tissues, validating the abnormal serum biochemistry. The neutralization study revealed that VPAV had limited efficacy against BRVV, suggesting the presence of venom proteins not fully neutralized by the antivenom. Altogether, these findings suggest that the Russell’s viper is a medically significant venomous snake in Bangladesh, and VPAV is only partially effective in reducing the venom’s toxic effects. Therefore, region‐specific venoms must be considered in antivenom development for more effective treatment in envenomation cases.
- Open Access
- 31 March 2023
- Published by Korea Genome Organization in Genomics & Informatics
- Vol. 21 (1) , e3
A bioinformatics approach to characterize a hypothetical protein Q6S8D9_SARS of SARS-CoV
Characterization as well as prediction of the secondary and tertiary structure of hypothetical proteins from their amino acid sequences uploaded in databases by in silico approach are the critical issues in computational biology. Severe acute respiratory syndrome–associated coronavirus (SARS-CoV), which is responsible for pneumonia alike diseases, possesses a wide range of proteins of which many are still uncharacterized. The current study was conducted to reveal the physicochemical characteristics and structures of an uncharacterized protein Q6S8D9_SARS of SARS-CoV. Following the common flowchart of characterizing a hypothetical protein, several sophisticated computerized tools e.g., ExPASy Protparam, CD Search, SOPMA, PSIPRED, HHpred, etc. were employed to discover the functions and structures of Q6S8D9_SARS. After delineating the secondary and tertiary structures of the protein, some quality evaluating tools e.g., PROCHECK, ProSA-web etc. were performed to assess the structures and later the active site was identified also by CASTp v.3.0. The protein contains more negatively charged residues than positively charged residues and a high aliphatic index value which make the protein more stable. The 2D and 3D structures modeled by several bioinformatics tools ensured that the proteins had domain in it which indicated it was functional protein having the ability to trouble host antiviral inflammatory cytokine and interferon production pathways. Moreover, active site was found in the protein where ligand could bind. The study was aimed to unveil the features and structures of an uncharacterized protein of SARS-CoV which can be a therapeutic target for development of vaccines against the virus. Further research are needed to accomplish the task.
- 31 March 2023
- Published by Korea Genome Organization in Genomics & Informatics
- Vol. 21 (1) , e3
Open AccessA bioinformatics approach to characterize a hypothetical protein Q6S8D9_SARS of SARS-CoV
Characterization as well as prediction of the secondary and tertiary structure of hypothetical proteins from their amino acid sequences uploaded in databases by in silico approach are the critical issues in computational biology. Severe acute respiratory syndrome–associated coronavirus (SARS-CoV), which is responsible for pneumonia alike diseases, possesses a wide range of proteins of which many are still uncharacterized. The current study was conducted to reveal the physicochemical characteristics and structures of an uncharacterized protein Q6S8D9_SARS of SARS-CoV. Following the common flowchart of characterizing a hypothetical protein, several sophisticated computerized tools e.g., ExPASy Protparam, CD Search, SOPMA, PSIPRED, HHpred, etc. were employed to discover the functions and structures of Q6S8D9_SARS. After delineating the secondary and tertiary structures of the protein, some quality evaluating tools e.g., PROCHECK, ProSA-web etc. were performed to assess the structures and later the active site was identified also by CASTp v.3.0. The protein contains more negatively charged residues than positively charged residues and a high aliphatic index value which make the protein more stable. The 2D and 3D structures modeled by several bioinformatics tools ensured that the proteins had domain in it which indicated it was functional protein having the ability to trouble host antiviral inflammatory cytokine and interferon production pathways. Moreover, active site was found in the protein where ligand could bind. The study was aimed to unveil the features and structures of an uncharacterized protein of SARS-CoV which can be a therapeutic target for development of vaccines against the virus. Further research are needed to accomplish the task.